Products for Research Use Only
RegisterLogin

Rinucumab

CAT: 0804-HY-P99402-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99402-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].
CAS Number
1569263-06-4
Product Name Alternative
REGN 2176
UNSPSC
12352203
Target
PDGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rinucumab.html
Purity
99.94
Solubility
10 mM in DMSO
Smiles
[Rinucumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Megan Cully, et al. Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration. Nat Rev Drug Discov. 2014 Jul;13 (7) :487.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
abx831359-01Rinucumab
GTR18337888-01Rinucumab Antibody
HY260016-01Research Grade Rinucumab
E55B0394Rinucumab (Reference antibody)
ICH5825-20mgRinucumab Biosimilar - Research Grade
A2378-1mgRinucumab (Anti-PDGFRB / CD140b)
GTR18780347-01(Rinucumab) Biosimilar Reference Antibody
047957PDGFRB/CD140b (rinucumab) discontinued
GTR18697828-01Rinucumab Human Monoclonal Antibody
592156Rinucumab (PDGFRB, PDGFR-1, CD140b)

Popular Products